Greenwood Keynotes BIO Annual Meeting June 20 In Philadelphia
This article was originally published in The Pink Sheet Daily
Keynote is Greenwood’s first as the biotech trade group’s president at its annual convention. The agenda also features CDER officials Galson, Throckmorton, and Cummins on drug safety.
You may also be interested in...
Ag/FDA subcommittee had tabled FDA hearing pending confirmation of a permanent agency commissioner. House cleared FDA 2006 spending in early June.
Amgen, J&J, Sanofi-Aventis, Pfizer, Merck, Roche, Lilly and Schering-Plough are scheduled to report results in upcoming week. Bristol could expand upon plans to sell OTC unit to Novartis the following week.
Homeland Security/Emergency Preparedness Subcommittee and Government Reform Committee hearings will focus on countermeasure procurement issues and evaluating the effectiveness of the BioShield Act of 2004.